Seelos Therapeutics Inc (SEEL)

[eicoman]

France Survey of Vitaros Satisfaction

http://www.sciencedirect.com/science/article/pii/S1158136016300329

Summary
Introduction
This study was carried out to assess how Vitaros®, a year after its release on the market, is being used to treat erectile dysfunction and how both patients and doctors perceive this drug.

Method
Observations were made of 117 physicians (sexual medicine specialist, urologist, or general practitionners), to evaluate how Vitaros® is actually be used.

Results
Seventy-two percent of these doctors were satisfied with Vitaros® after having prescribed it. Sixty-five percent of the patients who took it were satisfied or very satisfied – a percentage rises to 73 % when the prescribing doctor has explained to patients the need to take several doses before judging results, and to 79 % among patients to whom doctors prescribe it as a first-line treatment.

Conclusion
Vitaros®, the most recent pharmacological treatment of erectile dysfunction, broadens the supply of therapeutic resources offered to patients. Its effects can be optimized by associating the prescription with relevant information and by prescribing it as a first-line treatment.

http://www.journals.elsevier.com/sexologies
Sexologies
Volume 25, Issue 3, July–September 2016, Pages 128–132
Sexualité : handicaps et vulnérabilités — Rédacteur invité / Guest editor : Alain Giami